*	OR T2 T3
R1	Has_value Arg1:T6 Arg2:T7	
R2	Has_temporal Arg1:T6 Arg2:T8	
R3	Has_mood Arg1:T9 Arg2:T10	
R4	AND Arg1:T6 Arg2:T9	
*	OR T13 T14
R5	AND Arg1:T12 Arg2:T13	
*	OR T18 T19
*	OR T16 T17
R6	AND Arg1:T16 Arg2:T18	
R7	Has_temporal Arg1:T22 Arg2:T23	
R8	Has_value Arg1:T27 Arg2:T28	
R9	Has_temporal Arg1:T27 Arg2:T29	
R10	Has_value Arg1:T30 Arg2:T31	
R11	Has_temporal Arg1:T30 Arg2:T32	
*	OR T27 T30
R12	Has_value Arg1:T26 Arg2:T25	
R13	Subsumes Arg1:T26 Arg2:T27	
R14	Has_qualifier Arg1:T35 Arg2:T36	
R15	Has_qualifier Arg1:T36 Arg2:T37	
R16	Has_temporal Arg1:T35 Arg2:T38	
*	OR T46 T40 T41 T45 T42 T44 T39 T43
R17	Subsumes Arg1:T35 Arg2:T46	
R18	Has_qualifier Arg1:T51 Arg2:T49	
R19	Has_qualifier Arg1:T51 Arg2:T48	
R20	AND Arg1:T50 Arg2:T51	
R21	Has_value Arg1:T52 Arg2:T53	
*	OR T54 T55 T56
R22	Has_temporal Arg1:T54 Arg2:T57	
R23	AND Arg1:T59 Arg2:T60	
T1	Condition 0 21	Thalassemia syndromes
T2	Condition 24 54	Myelodysplastic syndrome (MDS)
T3	Condition 58 71	myelofibrosis
T4	Condition 74 97	Diamond Blackfan anemia
T5	Condition 100 127	Primary bone marrow failure
T6	Measurement 139 142	LIC
T7	Value 143 151	>30 mg/g
T8	Temporal 130 138	Baseline
T9	Procedure 168 171	MRI
T10	Mood 156 167	measured by
T11	Post-eligibility 175 303	Unable or unwilling to undergo a 7 day washout period if currently being treated with deferiprone or deferoxamine or deferasirox
T12	Procedure 315 343	discontinuation of treatment
T13	Condition 349 360	deferiprone
T14	Condition 364 376	deferoxamine
T16	Condition 424 440	hypersensitivity
T17	Condition 444 466	idiosyncratic reaction
T18	Drug 470 481	deferiprone
T19	Drug 485 497	deferoxamine
T22	Drug 513 524	hydroxyurea
T23	Temporal 525 539	within 30 days
T24	Condition 553 563	malignancy
T25	Value 578 586	abnormal
T26	Measurement 587 601	liver function
T27	Measurement 603 621	serum ALT level(s)
T28	Value 622 653	> 5 times upper limit of normal
T29	Temporal 654 666	at screening
T30	Measurement 670 687	creatinine levels
T31	Value 688 718	>2 times upper limit of normal
T32	Temporal 719 731	at screening
T35	Condition 746 762	unstable illness
T36	Qualifier 737 744	serious
T37	Qualifier 764 793	as judged by the Investigator
T38	Temporal 795 851	during the past 3 months before screening/baseline visit
T39	Condition 977 996	immunologic disease
T40	Condition 963 973;989 996	neurologic disease
T41	Condition 947 961;989 996	endocrinologic disease
T42	Condition 931 945;989 996	cardiovascular disease
T43	Condition 918 929;989 996	respiratory disease
T44	Condition 898 916;989 996	gastro-enterologic disease
T45	Condition 891 896;989 996	renal disease
T46	Condition 882 889;989 996	hepatic disease
T48	Qualifier 999 1021	Clinically significant
T49	Qualifier 1022 1030	abnormal
T50	Procedure 1031 1042	12-lead ECG
T51	Condition 1043 1051	findings
T52	Measurement 1054 1069	Cardiac MRI T2*
T53	Value 1070 1075	<10ms
T54	Condition 1078 1099	Myocardial infarction
T55	Condition 1101 1115	cardiac arrest
T56	Condition 1119 1134	cardiac failure
T57	Temporal 1135 1180	within 1 year before screening/baseline visit
T59	Condition 1183 1200	Unable to undergo
T60	Procedure 1201 1204	MRI
T61	Post-eligibility 1206 1423	Presence of metallic objects such as artificial joints, inner ear (cochlear) implants, brain aneurysm clips, pacemakers, and metallic foreign bodies in the eye or other body areas that would prevent use of MRI imaging
